Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

January 1, 2026

Study Completion Date

October 30, 2026

Conditions
Inflammatory DiseaseAging ProblemsObeseLipid Metabolism DisordersDiabetes
Interventions
BIOLOGICAL

umbilical cord mesenchymal stem cell

A total of 100 million single cells were suspended in 0.9% sterile saline solution and given intravenously at a 5-ml/min rate for 45 min. All patients will get two intravenous autologous infusions on days 0 (D0) and 90 (D90).

Trial Locations (1)

70000

DNA International Hospital, Ho Chi Minh City

All Listed Sponsors
lead

Nguyen Ton Ngoc Huynh

OTHER

NCT06448052 - Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation | Biotech Hunter | Biotech Hunter